학술논문

Siplizumab combination therapy with belatacept or abatacept broadly inhibits human T cell alloreactivity in vitro
Document Type
Article
Source
In: American Journal of Transplantation. (American Journal of Transplantation, October 2023, 23(10):1603-1611)
Subject
Language
English
ISSN
16006143
16006135